SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-20-105312
Filing Date
2020-09-15
Accepted
2020-09-15 17:29:08
Documents
38

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2024520-4_s1a.htm S-1/A 2741221
2 EXHIBIT 3.1 tm2024520d5_ex3-1.htm EX-3.1 31070
3 EXHIBIT 4.4 tm2024520d5_ex4-4.htm EX-4.4 59268
4 EXHIBIT 4.10 tm2024520d5_ex4-10.htm EX-4.10 26022
5 EXHIBIT 4.12 tm2024520d5_ex4-12.htm EX-4.12 71636
6 EXHIBIT 4.13 tm2024520d5_ex4-13.htm EX-4.13 70837
7 EXHIBIT 4.14 tm2024520d5_ex4-14.htm EX-4.14 61140
8 EXHIBIT 4.15 tm2024520d5_ex4-15.htm EX-4.15 24716
9 EXHIBIT 4.16 tm2024520d5_ex4-16.htm EX-4.16 9329
10 EXHIBIT 4.17 tm2024520d5_ex4-17.htm EX-4.17 50681
11 EXHIBIT 5.1 tm2024520d5_ex5-1.htm EX-5.1 15077
12 EXHIBIT 10.5 tm2024520d5_ex10-5.htm EX-10.5 122813
13 EXHIBIT 10.9 tm2024520d5_ex10-9.htm EX-10.9 111044
14 EXHIBIT 23.1 tm2024520d5_ex23-1.htm EX-23.1 2478
15 GRAPHIC lg_ikt.jpg GRAPHIC 525737
16 GRAPHIC tm2024520d1-bc_fiber4clr.jpg GRAPHIC 68002
17 GRAPHIC tm2024520d1-bc_measu4clr.jpg GRAPHIC 749462
18 GRAPHIC tm2024520d1-tbl_neuro4clr.jpg GRAPHIC 839454
19 GRAPHIC tm2024520d1-tbl_pipe4clr.jpg GRAPHIC 3051204
20 GRAPHIC tm2024520d4-bc_block4c.jpg GRAPHIC 2753805
21 GRAPHIC tm2024520d4-bc_grip4c.jpg GRAPHIC 1602441
22 GRAPHIC tm2024520d4-bc_inject4c.jpg GRAPHIC 2775320
23 GRAPHIC tm2024520d4-bc_vehicle4c.jpg GRAPHIC 1523083
24 GRAPHIC tm2024520d4-fc_valid4c.jpg GRAPHIC 1019989
25 GRAPHIC tm2024520d4-lc_damage4c.jpg GRAPHIC 1378433
26 GRAPHIC tm2024520d4-lc_tumor4c.jpg GRAPHIC 893208
27 GRAPHIC tm2024520d4-ph_activ4clr.jpg GRAPHIC 3364027
28 GRAPHIC tm2024520d4-ph_brain4c.jpg GRAPHIC 748088
29 GRAPHIC tm2024520d4-ph_patho4c.jpg GRAPHIC 7396378
30 GRAPHIC tm2024520d4-tbl_clinicbw.jpg GRAPHIC 2596789
31 GRAPHIC tm2024520d4-tbl_devel4clr.jpg GRAPHIC 1199738
32 GRAPHIC tm2024520d4-tbl_drug4c.jpg GRAPHIC 900075
33 GRAPHIC tm2024520d4-tbl_inhibit4c.jpg GRAPHIC 6736583
34 GRAPHIC tm2024520d4-tbl_neuro4c.jpg GRAPHIC 37998
35 GRAPHIC tm2024520d5_ex3-1img001.jpg GRAPHIC 3260
36 GRAPHIC tm2024520d5_ex3-1img002.jpg GRAPHIC 4316
37 GRAPHIC tm2024520d5_ex3-1img003.jpg GRAPHIC 4712
38 GRAPHIC tm2024520d5_ex5-1img01.jpg GRAPHIC 6811
  Complete submission text file 0001104659-20-105312.txt   58644373
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-240036 | Film No.: 201176835
SIC: 2836 Biological Products, (No Diagnostic Substances)